Trials / Completed
CompletedNCT00691171
Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use
Using an Electronic Health Record-based Intervention and Broad Education Reach Strategies to Improve Quality of Care for GERD and Gastroprotection for Patients on NSAIDs: a Randomized Controlled Trial
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,234 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.
Conditions
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-06-05
- Last updated
- 2015-04-15
Source: ClinicalTrials.gov record NCT00691171. Inclusion in this directory is not an endorsement.